Member Login

 
 
Forgot password/Login issues?
Not a Member? Learn more.
  • Blog
  • Partnership
  • Contact
  • Cart (0)
  • Member Login
bcc market research logo
Solution
  • Membership
    • Academic
    • Corporate
  • Market Research
  • Custom Research
  • Company Index
  • Scorecard
Industries
  • Life Sciences
    • Med Devices & Surgical
    • Cell Biology
    • Pharmaceuticals
    • Health Maintenance
  • Digital World
    • Instrumentation and Sensors
    • Safety and Security
    • Engineering
    • Photonics
    • Information Technology
  • Materials
    • Advanced Materials
    • Plastics
    • Chemicals
    • Semiconductor
    • Nanotechnology
  • Energy & Sustainability
    • Water-Membrane & Separations
    • Fuel Cell & Battery
    • Food
    • Energy
    • Manufacturing
    • Environment
Resources
  • e-Course
  • Spotlights Library
  • Megatrends
  • Association Exclusives
  • Market Research Studies
About
  • About BCC Research
  • Press Releases
  • Events
  • Careers
  • Contact
Beacon Search

Or Ask your question to the BCC Research BEACON Beacon Research

  1. Company Index
  2. GSK plc.
  3. News

GSK plc.

  • Overview
  • Financial
  • In Reports
  • Products
  • History
  • Point of Contacts
  • News

In News

GSK將收購efimosfermin,這是一種處於第三期臨床階段、可望成為同類最佳的專科藥物,用於治療和預防脂肪性肝病(SLD)的進展 - Business Wire

Business Wire - May 14, 2025

葛蘭素史克斥資 11.5 億美元收購 IDRx,擴展胃腸道癌症領域 - GeneOnline News

GeneOnline News - Jan 13, 2025

GSK的Arexvy疫苗正接受EMA審查用於成人使用 - Investing.com 香港

Investing.com 香港 - Jun 13, 2025

超10億美元!GSK(GSK.US)達成抗癌ADC療法合作協議美股US Stocks Quote - 外圍新聞內容Golbal News Content - AASTOCKS.com

AASTOCKS.com - Dec 05, 2024

新冠肺炎|GSK藥廠與CureVac研發第二代疫苗 針對病毒變種 - hk01.com

hk01.com - Feb 04, 2021

GSK新型抗生素在第三期臨床試驗中顯示前景樂觀 - Investing.com 香港

Investing.com 香港 - May 28, 2025

ViiV Healthcare宣佈美國FDA已核准首個且是唯一用於預防HIV的長效針劑Apretude(cabotegravir持續性藥效肌肉注射用懸浮劑) - Business Wire

Business Wire - Dec 23, 2021

葛蘭素史克反賄風暴仍將繼續 被罰30億只是壞日子開始 - news.cnyes.com

news.cnyes.com - Sep 22, 2014

BCC Research Beacon
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Thank you for your interest in BCC Research. You will be added to our mailing list.
Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
  • 781-489-7301
  • info@bccresearch.com
© 2025 BCC Research
Privacy Policy |Site Map|Terms & Conditions

Please select categories of interest:

Check All